Researchers assessed the efficacy and compared the relative effectiveness of various pharmacological treatments for alcohol use disorder.
Biogen edges out competition to win first FDA approval for Actemra biosimilar – Pharmaceutical Technology
Biogen has a biosimilar catalogue that generated $1.95bn in sales in Q2 2023. Image Credits: PictureDesignSwiss/Shutterstock. Biogen has entered the crowded arthritis market in the